Harrington Discovery Institute and Takeda Pharmaceutical Company announce the call for proposals for the 2018 Harrington Rare Disease Scholar Award.
The Harrington Rare Disease Scholar Award was created to advance breakthrough research into cures for rare diseases. The program is sponsored by Takeda Pharmaceutical Company and managed by Harrington Discovery Institute.
Who should apply?
- US-based MD and PhD researchers whose discoveries show promise for translation into novel treatments for rare diseases
Multi-Level Support for Award Recipients includes:
- $150,000 guaranteed; opportunity to qualify for up to $1,000,000.
- Drug development and project management support through the Harrington Discovery Institute's Innovation Support Center
- Facilitated access to Takeda’s research and development experts
- Dedicated pharma team for each scholar
- Clinical development strategy
- Regulatory guidance
Further details:
http://www.researchgate.net